Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Kim, Kuglae, Che, Tao, Panova, Ouliana, DiBerto, Jeffrey F., Lyu, Jiankun, Krumm, Brian E., Wacker, Daniel, Robertson, Michael J. +5 more·2020·Cell

Cited by (475)

Items 101–200 of 475

  1. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
    Elk Kossatz, Rebeca Dı́ez-Alarcia, Supriya A. Gaitonde, Carla Ramon‐Duaso, Tomasz Maciej Stępniewski, David Aranda-García, Itziar Muneta Arrate, Élodie Blondel-Tepaz, Suwipa Saen‐oon, Robert Soliva et al. · 2024 · Nature Communications
  2. Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors
    Yiwei Zhou, Jiyong Meng, Chanjuan Xu, Jianfeng Liu · 2021 · Frontiers in Cell and Developmental Biology
  3. Catalysts for change: the cellular neurobiology of psychedelics
    Matthew I. Banks, Zarmeen Zahid, N. Jones, Ziyad W. Sultan, Cody J. Wenthur · 2021 · Molecular Biology of the Cell
  4. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR
    Eline Pottie, Christophe Pol Stove · 2022 · Journal of Neurochemistry
  5. Cryo-EM structures of human bradykinin receptor-Gq proteins complexes
    Jinkang Shen, Dongqi Zhang, Yao Fu, Anqi Chen, Xiaoli Yang, Haitao Zhang · 2022 · Nature Communications
  6. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
    Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron J. Janowsky, Atheir I. Abbas · 2023 · Journal of Pharmacology and Experimental Therapeutics
  7. Atypical structural snapshots of human cytomegalovirus GPCR interactions with host G proteins
    Naotaka Tsutsumi, Shoji Maeda, Qianhui Qu, Martin Vögele, Kevin M. Jude, Carl‐Mikael Suomivuori, Ouliana Panova, Deepa Waghray, Hideaki E. KATO, Andrew Velasco et al. · 2022 · Science Advances
  8. Biased signaling in GPCRs: Structural insights and implications for drug development
    Yuanyuan Ma, Brandon Patterson, Lan Zhu · 2024 · Pharmacology & Therapeutics
  9. Dosing Psychedelics and MDMA
    Matthias E. Liechti, Friederike Holze · 2021 · Current topics in behavioral neurosciences
  10. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2AReceptor Agonists
    Christian B. M. Poulie, Eline Pottie, Ícaro A. Simon, Kasper Harpsøe, L. D’Andrea, Igor V. Komarov, David E.I. Gloriam, Anders A. Jensen, Christophe Pol Stove, Jesper Langgaard Kristensen · 2022 · Journal of Medicinal Chemistry
  11. Cryo-EM structure of the endothelin-1-ETB-Gi complex
    Fumiya K. Sano, Hiroaki Akasaka, Wataru Shihoya, Osamu Nureki · 2023 · eLife
  12. Molecular mechanism of the wake-promoting agent TAK-925
    Jie Yin, Yanyong Kang, Aaron P. McGrath, Karen Chapman, Megan Sjodt, Eiji Kimura, Atsutoshi Okabe, Tatsuki Koike, Yuhei Miyanohana, Yūji Shimizu et al. · 2022 · Nature Communications
  13. Cryo-EM structures of orphan GPR21 signaling complexes
    Xi Lin, Bo Chen, Yiran Wu, Yingqi Han, Ao Qi, Junyan Wang, Zhao Yang, Xiaohu Wei, Tingting Zhao, Lijie Wu et al. · 2023 · Nature Communications
  14. Structural insights into the peptide selectivity and activation of human neuromedin U receptors
    Chongzhao You, Yumu Zhang, Peiyu Xu, Sijie Huang, Wanchao Yin, H. Eric Xu, Yi Jiang · 2022 · Nature Communications
  15. A proximity proteomics pipeline with improved reproducibility and throughput
    Xiaofang Zhong, Qiongyu Li, Benjamin J. Polacco, Trupti Patil, Aaron Marley, Helene Foussard, Prachi Khare, Rasika S. Vartak, Jiewei Xu, Jeffrey F. DiBerto et al. · 2024 · Molecular Systems Biology
  16. Molecular mechanism of fatty acid activation of FFAR1
    Punita Kumari, Asuka Inoue, Karen Chapman, Peng Lian, Daniel M. Rosenbaum · 2023 · Proceedings of the National Academy of Sciences
  17. Structural basis of peptide recognition and activation of endothelin receptors
    2023
  18. A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
    Blerida Banushi, Vince Polito · 2023 · Biology
  19. Conformational transitions and activation of the adhesion receptor CD97
    Chunyou Mao, Ru-Jia Zhao, Ying-Jun Dong, Mingxin Gao, Li-Nan Chen, Chao Zhang, Peng Xiao, Jia Guo, Jiao Qin, Dandan Shen et al. · 2024 · Molecular Cell
  20. Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral perseverance
    Marc Duque, Alex Chen, Eric T. Hsu, Sujatha Narayan, Altyn Rymbek, Shahinoor Begum, Gesine Saher, Adam E. Cohen, David E. Olson, Yulong Li et al. · 2024 · Neuron
  21. Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
    Gabriele Floris, Konrad R. Dabrowski, Mary Tresa Zanda, Stephanie E. Daws · 2024 · Molecular Psychiatry
  22. Novel and atypical pathways for serotonin signaling
    Joël Bockaert, Carine Bécamel, Séverine Chaumont‐Dubel, Sylvie Claeysen, Franck Vandermoere, Philippe Marin · 2021 · Faculty Reviews
  23. Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E, protects human neurons against oxidative/neuroexcitotoxic stress via β-arrestin/ERK signaling
    Vinay Sharma, Xuyu Yang, Soo‐Kyung Kim, Amirhossein Mafi, Daniel Saiz‐Sánchez, Patricia Villanueva‐Anguita, Lan Xiao, Leila Toulabi, Asuka Inoue, William A. Goddard et al. · 2021 · Cellular and Molecular Life Sciences
  24. The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs
    Attila Egyed, Dóra Judit Kiss, György Miklós Keserű · 2022 · Frontiers in Pharmacology
  25. TRUPATH: An Open-Source Biosensor Platform for Interrogating the GPCR Transducerome
    Jeffrey F. DiBerto, Reid H. J. Olsen, Bryan L. Roth · 2022 · Methods in molecular biology
  26. The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
    Somdatta Saha, Javier González‐Maeso · 2023 · Neuropharmacology
  27. The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice
    Vladimir M. Pogorelov, Ramona M. Rodriguiz, Bryan L. Roth, William C. Wetsel · 2023 · Frontiers in Molecular Biosciences
  28. Molecular basis of human trace amine-associated receptor 1 activation
    Gregory Zilberg, Alexandra Kalia Parpounas, Audrey L. Warren, Shifan Yang, Daniel Wacker · 2024 · Nature Communications
  29. Conformation- and activation-based BRET sensors differentially report on GPCR–G protein coupling
    Shane C. Wright, Charlotte Avet, Supriya A. Gaitonde, Itziar Muneta Arrate, Christian Le Gouill, Mireille Hogue, Billy Breton, Stefania Koutsilieri, Rebeca Dı́ez-Alarcia, Madeleine Héroux et al. · 2024 · Science Signaling
  30. Molecular basis for the selective G protein signaling of somatostatin receptors
    Sijia Chen, Xiao Teng, Sanduo Zheng · 2022 · Nature Chemical Biology
  31. Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor
    Qing Wang, Yu Zhou, Jianhui Huang, Niu Huang · 2021 · Pharmaceuticals
  32. 5-HT2A SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics
    Gavin P. Schmitz, Manish Kumar Jain, Samuel T. Slocum, Bryan L. Roth · 2022 · ACS Chemical Neuroscience
  33. Animal Behavior in Psychedelic Research
    Anna U. Odland, Jesper Langgaard Kristensen, Jesper Tobias Andreasen · 2022 · Pharmacological Reviews
  34. Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile
    Rebeca Dı́ez-Alarcia, Carolina Muguruza, Guadalupe Rivero, Aintzane García‐Bea, Vanessa Gómez‐Vallejo, Luis Felipe Callado, Jordi Llop, Abraham Martín, J. Javier Meana · 2021 · Translational Psychiatry
  35. Structural insights into the human niacin receptor HCA2-Gi signalling complex
    Yang Yang, Hye Jin Kang, Ruogu Gao, Jingjing Wang, Gye Won Han, Jeffrey F. DiBerto, Lijie Wu, Jiahui Tong, Lu Qu, Yiran Wu et al. · 2023 · Nature Communications
  36. Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists
    Eline Pottie, Christian B. M. Poulie, Ícaro A. Simon, Kasper Harpsøe, L. D’Andrea, Igor V. Komarov, David E.I. Gloriam, Anders A. Jensen, Jesper Langgaard Kristensen, Christophe Pol Stove · 2023 · ACS Chemical Neuroscience
  37. Structural insights into endothelin receptor signalling
    Wataru Shihoya, Fumiya K. Sano, Osamu Nureki · 2023 · The Journal of Biochemistry
  38. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex <i>in vivo</i>
    Shao, Ling-Xiao, Liao, Clara, Gregg, Ian, Davoudian, Pasha A., Savalia, Neil K., Delagarza, Kristina, Kwan, Alex C. · 2021
  39. Structural basis of tethered agonism and G protein coupling of protease-activated receptors
    Jia Guo, Yunli Zhou, Yixin Yang, Shimeng Guo, Erli You, Xin Xie, Yi Jiang, Chunyou Mao, H. Eric Xu, Yan Zhang · 2024 · Cell Research
  40. Inactive and active state structures template selective tools for the human 5-HT5A receptor
    Shicheng Zhang, He Chen, Chengwei Zhang, Yang Ying, Petr A. Popov, Jing Liu, Brian E. Krumm, Can Cao, Kuglae Kim, Yan Xiong et al. · 2022 · Nature Structural & Molecular Biology
  41. Ligand selectivity hotspots in serotonin GPCRs
    Ícaro A. Simon, Walden Emil Bjørn-Yoshimoto, Kasper Harpsøe, Stylianos Iliadis, Bo R. Svensson, Anders A. Jensen, David E.I. Gloriam · 2023 · Trends in Pharmacological Sciences
  42. The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
    Bryan R. Barksdale, Manoj K. Doss, Gregory A. Fonzo, Charles B. Nemeroff · 2024 · Neurotherapeutics
  43. Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity
    Bruno Gianfratti, Ricardo Tabach, Marna Eliana Sakalem, Talita Stessuk, Lucas Oliveira Maia, E.A. Carlini · 2021 · Journal of Ethnopharmacology
  44. Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
    Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen, B. Roberts, Jon H. Sciortino, William J. Gibbons, Lucas M. Friedberg et al. · 2024 · British Journal of Pharmacology
  45. Agonist and antagonist TRUPATH assays for G protein-coupled receptors
    Jeffrey F. DiBerto, Katie Smart, Reid H. J. Olsen, Bryan L. Roth · 2022 · STAR Protocols
  46. A non-canonical mechanism of GPCR activation
    Alexander S. Powers, Aasma A. Khan, Joseph M. Paggi, Naomi R. Latorraca, Sarah Souza, Jerry Di Salvo, Jun Lu, Stephen M. Soisson, Jennifer M. Johnston, Adam B. Weinglass et al. · 2024 · Nature Communications
  47. Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: <i>In Vitro</i> Functional Evaluation and Molecular Docking
    Pottie, Eline, Kupriyanova, Olga V., Brandt, Asher L., Laprairie, Robert B., Shevyrin, Vadim A., Stove, Christophe P. · 2021 · ACS Pharmacology &amp; Translational Science
  48. Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A
    Yangxia Tan, Peiyu Xu, Sijie Huang, Gong Yang, Fulai Zhou, Xinheng He, Honglei Ma, H. Eric Xu, Yi Jiang · 2022 · Cell Discovery
  49. Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
    Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt · 2023 · Cells
  50. A force-sensitive adhesion GPCR is required for equilibrioception
    Zhao Yang, Shuhua Zhou, Qiyue Zhang, Zhi-Chen Song, Wenwen Liu, Yu Sun, Ming-Wei Wang, Xiaolong Fu, Kongkai Zhu, Ying Guan et al. · 2025 · Cell Research
  51. 25CN‐NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor
    Emil Märcher-Rørsted, Anders A. Jensen, Jesper Langgaard Kristensen · 2021 · ChemMedChem
  52. Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand-binding specificity
    2022
  53. A Prelimbic Cortex-Thalamus Circuit Bidirectionally Regulates Innate and Stress-Induced Anxiety-Like Behavior
    Sheng-Rong Zhang, Dingyu Wu, Rong Luo, Jianlin Wu, Hao Chen, Zi-Ming Li, Jia-Pai Zhuang, Neng-Yuan Hu, Xiaowen Li, Jian‐Ming Yang et al. · 2024 · Journal of Neuroscience
  54. Structural basis of ligand recognition and activation of the histamine receptor family
    Xuan Zhang, Guibing Liu, Ya-Ni Zhong, Ru Zhang, Chuan-Cheng Yang, Canyang Niu, Xuanyu Pu, Jingjing Sun, Tianyao Zhang, Lejin Yang et al. · 2024 · Nature Communications
  55. Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor
    Dohyun Im, Jun-ichi Kishikawa, Yuki Shiimura, Hiromi Hisano, Akane Ito, Yoko Fujita, Yukihiko Sugita, Takeshi Noda, Takayuki Kato, Hidetsugu Asada et al. · 2023 · Nature Communications
  56. Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2
    Jae-Hyun Park, Kouki Kawakami, Naito Ishimoto, Tatsuya Ikuta, Mio Ohki, Toru Ekimoto, Mitsunori Ikeguchi, Dong‐Sun Lee, Young‐Ho Lee, Jeremy R. H. Tame et al. · 2023 · Nature Communications
  57. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice
    Mario de la Fuente Revenga, Urjita H. Shah, Nima Nassehi, Alaina M. Jaster, Prithvi Hemanth, Salvador Sierra, Maƚgorzata Dukat, Javier González‐Maeso · 2021 · ACS Chemical Neuroscience
  58. Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT2B Receptors
    Katrin Denzinger, Trung Ngoc Nguyen, Theresa Noonan, Gerhard Wolber, Marcel Bermúdez · 2020 · International Journal of Molecular Sciences
  59. Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice
    Xiaoqian Liu, Huili Zhu, Huan Fang Gao, Xiangyun Tian, Bo Tan, Ruibin Su · 2022 · Biochemical and Biophysical Research Communications
  60. Ligand-induced activation and G protein coupling of prostaglandin F2α receptor
    Canrong Wu, Youwei Xu, Qian He, Dianrong Li, Jia Duan, Changyao Li, Chongzhao You, Han Chen, Weiliang Fan, Yi Jiang et al. · 2023 · Nature Communications
  61. Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT 2A Receptor by a Light‐Controllable N , N ‐Dimethyltryptamine Derivative
    Hubert Gerwe, Feng He, Eline Pottie, Christophe Pol Stove, Michael W. Decker · 2022 · Angewandte Chemie International Edition
  62. Effect of Ligands and Transducers on the Neurotensin Receptor 1 Conformational Ensemble
    Austin D. Dixon, Asuka Inoue, Scott A. Robson, Kelly J. Culhane, Jonathan C. Trinidad, Sivaraj Sivaramakrishnan, Fabian Bumbak, Joshua J. Ziarek · 2022 · Journal of the American Chemical Society
  63. Structural basis of agonist specificity of α1A-adrenergic receptor
    Minfei Su, Jinan Wang, Guoqing Xiang, Hung Nguyen Do, Joshua Levitz, Yinglong Miao, Xin‐Yun Huang · 2023 · Nature Communications
  64. Allosteric modulation and biased signalling at free fatty acid receptor 2
    Xuan Zhang, Abdul-Akim D. Guseynov, Laura Jenkins, Alice Valentini, Sara Marsango, Katrine Schultz-Knudsen, Trond Ulven, Elisabeth Rexen Ulven, Irina G. Tikhonova, Graeme Milligan et al. · 2025 · Nature
  65. Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
    Zheng Xu, Hongshuang Wang, Jingjing Yu, Yue Deng, Xiaowen Tian, Rongjun Ni, Fan Xia, Lingyi Yang, Chanjuan Xu, Liting Zhang et al. · 2026 · Nature
  66. Ligand-Dependent Conformational Transitions in Molecular Dynamics Trajectories of GPCRs Revealed by a New Machine Learning Rare Event Detection Protocol
    Ambrose Plante, Harel Weinstein · 2021 · Molecules
  67. Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
    Anton Gomez-Escolar, Daniel Folch‐Sanchez, Joanna Stefaniuk, Zoe Swithenbank, Andreia Nisa, Fleur Braddick, Nazish Idrees Chaudhary, Pim B. van der Meer, Albert Batalla · 2024 · CNS Drugs
  68. Exploring the distinct activation mechanisms of neuromedin B receptor through multiple replica molecular dynamics simulations and Markov state modeling
    Nuan Li, Ming-Yuan Yang, Mingyang Zhang, Ning Liu, Ai-wu Zhou, Zong‐Tao Chai, Shaoyong Lu · 2025 · Acta Pharmacologica Sinica
  69. β2-adrenoceptor ligand efficacy is tuned by a two-stage interaction with the Gαs C terminus
    Keehun Kim, Shayla Paulekas, Fredrik W. Sadler, Tejas M. Gupte, Michael Ritt, Matthew Dysthe, Nagarajan Vaidehi, Sivaraj Sivaramakrishnan · 2021 · Proceedings of the National Academy of Sciences
  70. Structural insights into the G protein selectivity revealed by the human EP3-Gi signaling complex
    Ryoji Suno, Yukihiko Sugita, Kazushi Morimoto, Hiroko Takazaki, Hirokazu Tsujimoto, Mika Hirose, Chiyo Suno-Ikeda, Norimichi Nomura, Tomoya Hino, Asuka Inoue et al. · 2022 · Cell Reports
  71. Antidepressant- and anxiolytic-like actions of Cajanus cajan seed extract mediated through monoaminergic, nitric oxide-cyclic GMP and GABAergic pathways
    Taiwo Grace Olubodun-Obadun, Ismail Ogunbayode Ishola, Timisola P. Adesokan, Blessing O. Anih, Olufunmilayo Olaide Adeyemi · 2023 · Journal of Ethnopharmacology
  72. Mechanism of agonist-induced activation of the human itch receptor MRGPRX1
    Bing Siang Gan, Leiye Yu, Haifeng Yang, Haizhan Jiao, Bin Pang, Yi‐An Chen, Chen Wang, Rui Lv, Hongli Hu, Zhijian Cao et al. · 2023 · PLoS Biology
  73. Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations
    Aaron S. Wolfgang, Charles W. Hoge · 2023 · Current Psychiatry Reports
  74. Psychedelic-like Activity of Norpsilocin Analogues
    Alexander M. Sherwood, Elise K. Burkhartzmeyer, Samuel E. Williamson, Michael H. Baumann, Grant C. Glatfelter · 2024 · ACS Chemical Neuroscience
  75. Structural determinants of cholesterol recognition in helical integral membrane proteins
    Brennica Marlow, Georg Kuenze, Bian Li, Charles R. Sanders, Jens Meiler · 2021 · Biophysical Journal
  76. Psychedelics: preclinical insights provide directions for future research
    Ryan H. Gumpper, Bryan L. Roth · 2023 · Neuropsychopharmacology
  77. Back to the Future — The Therapeutic Potential of Psychedelic Drugs
    Jeffrey Alan Lieberman · 2021 · New England Journal of Medicine
  78. Toluene Toxicity in the Brain: From Cellular Targets to Molecular Mechanisms
    Andrew Shaw, Jeffery D. Steketee, Anna N. Bukiya, Alex M. Dopico · 2025 · The Annual Review of Pharmacology and Toxicology
  79. Emerging mechanisms of psilocybin-induced neuroplasticity
    Sonia Sonda, Diana Pendin, Stefano Comai, Sara De Martin, Paolo Manfredi, Andrea Mattarei · 2025 · Trends in Pharmacological Sciences
  80. A suite of engineered mice for interrogating psychedelic drug actions
    Yi-Ting Chiu, Ariel Y. Deutch, Wei Wang, Gavin P. Schmitz, Karen Lu Huang, D. Dewran Koçak, Pierre Llorach, Kasey Bowyer, Bei Liu, Noah Sciaky et al. · 2026 · Nature Neuroscience
  81. Ligand bias and inverse agonism on 5‐HT2A receptor‐mediated modulation of G protein activity in post‐mortem human brain
    Itziar Muneta Arrate, Patrícia Miranda-Azpiazu, Igor Horrillo, Rebeca Dı́ez-Alarcia, J. Javier Meana · 2024 · British Journal of Pharmacology
  82. Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis
    Giorgia Caspani, Simon Ruffell, WaiFung Tsang, Nigel Netzband, Cyrus Rohani-Shukla, Jonathan Richard Swann, Wilfred Arthur Jefferies · 2024 · Pharmacological Research
  83. Biased GPCR Signaling: Possible Mechanisms and Therapeutic Applications
    Luyu Fan, Sheng Wang · 2025 · Biochemistry
  84. Evidence that 5‐HT 2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs
    Aurelija Ippolito, Sridhar R. Vasudevan, Shaun Hurley, Gary Gilmour, Frederick G. Westhorpe, Grant C. Churchill, Trevor Sharp · 2025 · British Journal of Pharmacology
  85. Effects of Membrane Cholesterol on the Structure and Function of Selected Class A GPCRs─Challenges and Future Perspectives
    Marina Christofidi, Eva Tzortzini, Thomas Mavromoustakos, Antonios Kolocouris · 2025 · Biochemistry
  86. Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation
    Gavin P. Schmitz, Yi-Ting Chiu, Mia L. Foglesong, Sarah N. Magee, Martin MacKinnon, Gabriele Maria König, Evi Kostenis, Li-Ming Hsu, Yen-Yu I. Shih, Bryan L. Roth et al. · 2025 · Translational Psychiatry
  87. Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators
    Jianping Chen, Erik J. Garcia, Christina R. Merritt, Joshua C. Zamora, Andrew A. Bolinger, Konrad Pazdrak, Susan J Stafford, Randy C. Mifflin, Eric A. Wold, Christopher Wild et al. · 2023 · Journal of Medicinal Chemistry
  88. Insights into cellular signaling from membrane dynamics
    Parijat Sarkar, Amitabha Chattopadhyay · 2021 · Archives of Biochemistry and Biophysics
  89. Development of Generic G Protein Peptidomimetics Able to Stabilize Active State Gs Protein‐Coupled Receptors for Application in Drug Discovery
    Morgane Mannes, Charlotte Martin, Sarah Triest, Marilisa Pia Dimmito, Adriano Mollica, Toon Laeremans, Christel J. Menet, Steven Ballet · 2021 · Angewandte Chemie International Edition
  90. Serotonin (5-HT) 2A Receptor Involvement in Melanin Synthesis and Transfer via Activating the PKA/CREB Signaling Pathway
    Yunyun Yue, Min Zhong, Xiaohong An, Qingyuan Feng, Yifan Lai, Meng Yu, Xiaofeng Zhang, Zixian Liao, Ming‐Han Chen, Jing Dong et al. · 2022 · International Journal of Molecular Sciences
  91. Cellular rules underlying psychedelic control of prefrontal pyramidal neurons
    Tyler G. Ekins, Isla A. W. Brooks, Sameer Kailasa, Chloe Rybicki-Kler, Izabela Jedrasiak‐Cape, Ethan Donoho, George A. Mashour, Jason C. Rech, Omar J. Ahmed · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy
    Chunyu Wang, Nan Zhang, Yujie Shao, Tao Li, Mengna Zhang, Meng Gao, Yaqi Liang, Yumeng Wang, Tian Xue, Yiming Shi et al. · 2025 · Cell
  93. A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines
    Chen Xue, Jing Li, Lisa X Yu, Francesca Maule, Limei Chang, Jonathan A. Gallant, David J. Press, Sheetal A. Raithatha, Jillian M. Hagel, Peter J. Facchini · 2023 · Journal of Biological Chemistry
  94. Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification
    Giuseppe Floresta, Vincenzo Abbate · 2021 · RSC Advances
  95. OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz
    Alastair C. Keen, Maria Hauge Pedersen, Laura Lemel, Daniel J. Scott, Meritxell Canals, Dene R. Littler, Travis Beddoe, Yuki Ono, Lei Shi, Asuka Inoue et al. · 2022 · Communications Biology
  96. Molecular recognition of itch-associated neuropeptides by bombesin receptors
    Changyao Li, Youwei Xu, Heng Liu, Hongmin Cai, Yi Jiang, H. Eric Xu, Wanchao Yin · 2022 · Cell Research
  97. G Protein-coupled Receptor (GPCR) Reconstitution and Labeling for Solution Nuclear Magnetic Resonance (NMR) Studies of the Structural Basis of Transmembrane Signaling
    Haoyi Ge, Huixia Wang, Benxun Pan, Dandan Feng, Canyong Guo, Lingyun Yang, Dongsheng Liu, Kurt Wüthrich · 2022 · Molecules
  98. Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties
    Mazen A. Atiq, Matthew R. Baker, Jennifer L. Vande Voort, Maxemiliano V. Vargas, Doo‐Sup Choi · 2024 · Psychopharmacology
  99. The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules
    Kexin Jiang, You Yi Zheng, Liting Zeng, Lingling Wang, Fei Li, Jun Pu, Yingli Lu, Suwen Zhao, Fei Xu · 2024 · Cell Reports
  100. Molecular mechanism of prolactin-releasing peptide recognition and signaling via its G protein-coupled receptor
    Yang Li, Qingning Yuan, Xinheng He, Yumu Zhang, Chongzhao You, Canrong Wu, Jingru Li, H. Eric Xu, Lihua Zhao · 2024 · Cell Discovery